Authored by: Karla K. Mioduchoski, FNP-BC Clinic: Miami Bariatric And Plastic Surgery, MD
Miami Bariatric And Plastic Surgery MD provides comprehensive Tesamorelin consultation and prescription evaluation. Through our secure telehealth platform, we serve patients across the greater Miami area.
📞 Call: (786) 294-6054 💻 Telehealth Consultations: Available Anywhere in Miami & Florida
Key Takeaways
Tesamorelin is a synthetic Growth Hormone–Releasing Hormone (GHRH) analog. It is FDA-approved under the brand name Egrifta® for HIV-associated lipodystrophy, a condition involving abnormal fat distribution.
Outside of that indication, Tesamorelin may be discussed in select cases under medical supervision when clinically appropriate. Any use beyond FDA-approved labeling is considered off-label and requires individualized evaluation.
Tesamorelin stimulates the pituitary gland to release the body’s natural growth hormone. Growth hormone plays a crucial role in metabolic regulation and body composition. Because hormonal pathways are complex, therapy must be carefully monitored. Not all patients are appropriate candidates.
You may be considered for a consultation if you:
Note: Eligibility is determined only after a thorough medical assessment. Not all individuals qualify.
Your evaluation at Miami Bariatric and Plastic Surgery MD, may include:
Treatment is never initiated without proper medical clearance.
Medication: Tesamorelin (GHRH Analog)
Home Delivery: Nationwide
Schedule: 5 days/week (subcutaneous injection)
Program Length: 3 months minimum
Note:
If a patient requires a higher dose, pricing and the program may be adjusted based on the provider’s recommendation and evaluation.
| Duration | Frequency | Price | Notes |
|---|---|---|---|
| Weekly | 5 days/week | $50/week | Based on full 3-month plan |
| Monthly | 5 days/week | $200/month | Includes supplies (Based on full 3-month plan) |
| 3-Month Program | Full plan | $600 total | Medical support + home delivery |
Consultation Fee: $99 (In-office or Telehealth)
Transparent pricing. No surprises. No hidden fees.
Disclaimer:
Pricing shown is based on a 3-month starting dose. Final dosage and treatment plan will be determined during a medical consultation with a licensed healthcare provider.
Tesamorelin is administered by subcutaneous injection (under the skin), typically in the abdominal region. Patients who qualify may receive:
Dose adjustments may occur based on your physiological response and safety parameters.
In its FDA-approved use (HIV-associated lipodystrophy), Tesamorelin has demonstrated a reduction of visceral abdominal fat. For off-label uses, outcomes vary and are not guaranteed.
Possible side effects may include:
Any concerning symptoms should be reported to our clinical team promptly.
Tesamorelin may not be appropriate for everyone. It should not be used in patients with:
All contraindications are extensively reviewed prior to prescribing.
Tesamorelin (Egrifta®) may qualify for insurance coverage when prescribed for its FDA-approved indication of HIV-associated lipodystrophy. For off-label use, insurance coverage is typically not guaranteed, and treatment is usually self-pay. Financial options and pricing are discussed during your consultation.
Hormonal therapies should never be self-directed or obtained from unregulated online sources. Unverified products may contain inaccurate dosing, be contaminated, lack sterility, or be mislabeled. At Miami Bariatric and Plastic Surgery, all prescribing decisions are made within a structured, safe medical framework.
Miami Bariatric And Plastic Surgery MD provides comprehensive, 100% virtual telehealth consultations for patients throughout the greater Miami area.
Our fully integrated telehealth platform allows eligible patients to receive expert medical evaluations, prescription management, and ongoing support entirely from the comfort and privacy of their own homes—eliminating the need for in-office visits. We frequently serve patients through our virtual clinic across Miami communities, including Brickell, Coconut Grove, Wynwood, Little Havana, Edgewater, the Design District, and Midtown.
If a provider determines that Tesamorelin therapy may be appropriate, a prescription is required. Treatment begins only after medical review, discussion of potential risks, and informed consent.
Disclaimer #1 – Medical Information: This content is for educational purposes only and does not constitute medical advice. Treatment decisions should be made only after consultation with a licensed healthcare provider.
Disclaimer #2 – Regulatory & Off-Label Use: Tesamorelin (Egrifta®) is FDA-approved for HIV-associated lipodystrophy. Any use outside of its approved labeling is considered off-label and is prescribed only when medically appropriate. Results vary and are not guaranteed.